What does this article add?
In the largest prospective AF dataset from the Balkans, more than one
third of patients received a rhythm control strategy, and these patients
tended to be younger with less comorbidities than those managed with
rate control. EHRA symptom score is not significantly associated with
rhythm control. The most commonly used antiarrhythmic agents were
amiodarone, followed by propafenone.